Our Why
Better drug development starts with better trial designs.
Inspired by Bayesian thinking, we optimize early-phase development and help build strong foundations for success.
The Problem with the CRO Model
- No specialization in biostatistics
- Small pharma/biotech companies don't get the 'A Team'
- Complicated, inflexible budgets
- Excessive bureaucracy and change orders
- Slow turnaround and delivery times
What We Offer
- A-team level statistical support
- Broader range of advanced statistical tools
- Quick turnaround via process automation
- Flexible, simplified engagement models
Why Statistical Methodology Matters
- Small sample sizes: Data efficiency is key.
- High uncertainty: Good statistics bridge early data gaps.
- Better foundation: Strong Phase 1/2 methods reduce Phase 3 failures (source).
Beyond the 3+3 Design
The traditional 3+3 design only identifies the correct dose about 30% of the time (source).
Our Bayesian methods increase the correct dose identification rate to 70–75%, enhancing trial success and patient safety.
Our Values
Our business is guided by our three corporate values which reflect the way we work with our customers.
Empowerment
Empowerment is the key to innovation.
Quality
Quality is the essence of success.
Honesty
Honesty is the foundation of any good business relation.